BioAge Labs, Inc. (BIOA) reporting calendar
BioAge Labs, Inc. files periodic reports with the SEC as BIOA on Nasdaq. Atlas tracks 7 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 15 Jul 2026 – 30 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 8 May 2026
- Reports on record
- 7
How this window is derived. Derived from this issuer's own filing history: 7 periods at a median 91-day cadence, filed a median 38 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open BIOA market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 8 May 2026 | 38 days | 0001193125-26-213466 |
| 10-K | 31 Dec 2025 | 24 Mar 2026 | 83 days | 0001193125-26-120873 |
| 10-Q | 30 Sep 2025 | 6 Nov 2025 | 37 days | 0001193125-25-270012 |
| 10-Q | 30 Jun 2025 | 6 Aug 2025 | 37 days | 0000950170-25-104176 |
| 10-Q | 31 Mar 2025 | 6 May 2025 | 36 days | 0000950170-25-064552 |
| 10-K | 31 Dec 2024 | 20 Mar 2025 | 79 days | 0000950170-25-042759 |
| 10-Q | 30 Sep 2024 | 7 Nov 2024 | 38 days | 0000950170-24-123445 |
Source: SEC EDGAR company submissions for CIK 0001709941. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.